Patient: Page 2


  • Colorful drug capsules against a yellow background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The stories you’ve read the most in 2023 (so far)

    From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.

    By PharmaVoice Staff • July 3, 2023
  • Covid-19 illustration with dark blue background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A unique study on COVID shows how machine learning can help personalize medicine

    Based on real-world data from patients in China, researchers were able to pinpoint factors that led to recurring infections — and which drug combos helped.

    By Kelly Bilodeau • June 26, 2023
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Close up overhead view of full prescription bottles on stainless steel background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    Is America ready for a new kind of opioid?

    Tris Pharma’s CEO is “betting the company” on a pain reliever with the power of an opioid and a lower chance of addiction. 

    By Alexandra Pecci • June 12, 2023
  • Broken chocolate-chip cookie.
    Image attribution tooltip

    iStock / t_kimura

    Image attribution tooltip
    Sponsored by Adheris Health

    First-party data: The answer to a cookie-less future

    While online cookies revolutionized online advertising and are a big part of a $600 billion dollar industry, targeting consumer/patient behavior is about to get much more difficult

    By Heather Campbell, VP Marketing, Adheris Health • June 12, 2023
  • mushroom brain
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Why cancer could be the ideal realm for psychedelic treatments

    The CEO of Sunstone Therapies said the results of a recent trial testing psilocybin in cancer patients with depression were “remarkable.”

    By June 9, 2023
  • Christy Shafer Marinus
    Image attribution tooltip
    Permission granted by Marinus Pharmaceuticals
    Image attribution tooltip
    Podcast

    Woman of the Week: Marinus Pharmaceuticals’ Christy Shafer

    The chief commercial officer shares how the company “beat the odds” to bring a rare disease drug to market.

    By June 7, 2023
  • pills rising
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

    Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

    By June 2, 2023
  • CVS storefront
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    CVS is exiting clinical trials. Does this spell trouble for retail-based research?

    Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.

    By Kelly Bilodeau • May 30, 2023
  • DMD
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Amid surging Duchenne market, Capricor touts potential ‘backbone’ therapy of the space

    The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients. 

    By Kelly Bilodeau • May 22, 2023
  • Veronica Sandoval Genentech
    Image attribution tooltip
    Permission granted by Veronica Sandoval
    Image attribution tooltip
    Podcast

    Woman of the Week: Genentech’s Veronica Sandoval

    How the Genentech diversity exec is using ‘three Ms’ to reduce health disparities and improve access for under-supported communities.

    By May 17, 2023
  • Ashley Hall Reneo Pharmaceuticals
    Image attribution tooltip
    Permission granted by Ashley Hall Reneo Pharmaceuticals
    Image attribution tooltip
    Podcast

    Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall

    After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.

    By May 10, 2023
  • Christopher Boone AbbVie
    Image attribution tooltip
    Permission granted by Christopher Boone AbbVie
    Image attribution tooltip
    Q&A

    AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’

    With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.

    By May 10, 2023
  • Daniela Marino headshot
    Image attribution tooltip
    Permission granted by Daniela Marino
    Image attribution tooltip
    Profile

    This ‘hot-blooded’ CEO is aiming to transform the way burn victims heal

    Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.

    By Alexandra Pecci • May 9, 2023
  • A person holds an insulin pen
    Image attribution tooltip
    agrobacter via Getty Images
    Image attribution tooltip

    Insulin prices have dropped — will Civica still be a disrupter in the field?

    The nonprofit generics maker still sees a need for low-cost insulin despite recent moves by major drugmakers to slash the prices of their popular products. 

    By May 8, 2023
  • Neena Patil Jazz Pharmaceuticals
    Image attribution tooltip
    Permission granted by Neena Patil
    Image attribution tooltip
    Podcast

    Woman of the Week: Jazz Pharmaceuticals’ Neena Patil

    Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

    By May 3, 2023
  • lowering sperm count
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Scientists could finally be closing in on a ‘pill’ for men

    Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.

    By Kelly Bilodeau • April 26, 2023
  • Elle de Groot Brii Bioscience
    Image attribution tooltip
    Permission granted by Elle de Groot
    Image attribution tooltip
    Podcast

    Woman of the Week: Brii Biosciences’ Ellee de Groot

    A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

    By April 19, 2023
  • Young people sitting on the stairs and using smartphones.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Patient influencers are here to stay — where are the regulations?

    As social media health influencers enter the world of pharma advertising, experts warn that more guardrails are needed to protect the industry and patients.

    By April 17, 2023
  • Julia Lakeland uMotif
    Image attribution tooltip
    Permission granted by Julia Lakeland uMotif
    Image attribution tooltip
    Podcast

    Woman of the Week: uMotif’s Julia Lakeland

    The chief product officer’s work in transforming clinical trial technology is driven by people.

    By April 12, 2023
  • A councelor comforting her emotional patient and taking notes during therapy session.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What’s pharma doing wrong to improve trial diversity? ‘Everything’

    Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.

    By April 12, 2023
  • blood sample tubes
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Where one unicorn struggled, another biotech is aiming for a diabetes win

    Intarcia looked poised to break into a lucrative diabetes implant market but has been dogged by safety issues — now Vivani thinks it’s found a way to succeed.

    By Kelly Bilodeau • April 10, 2023
  • Shot of a young woman using a cellphone while relaxing at home
    Image attribution tooltip
    Adene Sanchez via Getty Images
    Image attribution tooltip
    Sponsored by GoodRx

    GoodRx Health is the one-stop-shop for patients — and marketers

    Optimize patient conversion through a single platform with GoodRx: the one-stop-shop for patients — and marketers.

    April 10, 2023
  • Peyton Howell Parexel
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Q&A

    5 minutes with — Parexel’s Peyton Howell

    The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

    By April 7, 2023
  • A scientist with protective eyeglasses and mask holding a red transparent pill with fingers in gloves in the pharmaceutical research laboratory
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A drug just launched for a disease discovered only 10 years ago

    Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.

    By April 6, 2023
  • cardio
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Amgen’s aim for a ‘moonshot’ in cardiovascular disease

    A VP of global development at Amgen explains how treating general medicine diseases could one day resemble approaches in oncology.  

    By April 5, 2023